Method,
borrowed from clinical research.
Structured intake.
Six minutes.
A structured digital intake records your symptoms, goals, prior peptide use, medications, and contraindications. The instrument was adapted from validated screening tools — DAST, AUDIT-C, PHQ-2 — for the questions that matter to peptide candidacy.
The intake selects the panel that can answer the relevant question. If your symptoms point to the HPG axis, the Sexual Health panel is suggested. If they point to recovery, the Recovery panel is suggested. You can override the suggestion at any time.
Venous draw, anywhere
that runs CLIA.
A requisition routes to Quest or Labcorp through Junction's clinical integration platform. Walk into any of 4,500+ patient service centers; the draw takes ten minutes. Fasting is required for the metabolic subpanel; otherwise no preparation.
Specimens are processed under CLIA-certified protocols. Reference ranges are age-stratified from NHANES and in-house population data. We do not use a single set of "optimal" ranges across age bands — a 28-year-old's IGF-1 reference is not a 58-year-old's.
An annotated report.
Every flag, a citation.
Results return as a structured report. Flagged biomarkers are annotated to the peptide literature — author, journal, year, PMID. Recommendations include a candidate stack, dosing windows drawn from trial protocols, and an explicit contraindication section.
We do not prescribe and we do not sell peptides. The report is shareable as a PDF with your physician, who can determine whether to write a prescription. Our role ends with the citation; the clinical decision is yours and your physician's.
Order Monday,
discuss with your physician next Tuesday.
The four rules
that govern every report.
i. No flag without a citation.
Every recommendation is anchored to a published source. Where the literature is preclinical, we say so. Where it is RCT-grade, we say so.
ii. No recommendation without contraindications.
Every protocol carries an explicit contraindications block. We do not assume the subject reads small print elsewhere — it's on the page next to the dose.
iii. No protocol without a monitoring schedule.
Every report includes a 12-week monitoring schedule with reassessment triggers — biomarker thresholds at which the protocol should be held.
iv. No conflict of interest with a vendor.
We do not sell peptides. We do not compound. We do not take commissions from compounding pharmacies. The report is independent of any downstream supply chain.
Begin with the question.
The peptide comes after.
Six minutes of intake, then a lab visit. We'll do the indexing.
Begin intake →